SHERI SHAFFER: Open Payments
NPI 1255844809 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 44 payments from 15 companies in 2025. Trend: 2023 $1,177 · 2024 $975 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $295 |
| Lilly USA, LLC | 4 | $73 |
| Exact Sciences Corporation | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $35 |
Products named: Ozempic, Wegovy, JARDIANCE, The Cologuard Plus Collection Kit, GARDASIL 9, ZORYVE, MOUNJARO, NEXLETOL.
Industry payments across FL — which companies pay providers there.
